🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well venetoclax and ibrutinib work in treat...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-07-07
Trial ID
NCT02756897
Treatments Being Tested
Patients enrolled to the study had chronic lymphocytic leukemia (CLL) and r...
Status
Terminated
Location
University of California San Diego - Moores Cancer Center
Start Date
2018-04-09
Trial ID
NCT03400176
This is an investigator-initiated Phase 2 study, which combines R-EDOCH wit...
Status
Unknown
Location
Peking university Third Hospital
Start Date
2021-08-30
Trial ID
NCT04992377
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ibrutinib (PCI-327...
Status
Completed
Location
UCLA Medical Center
Start Date
2011-05
Trial ID
NCT01325701
Treatments Being Tested
A Phase I Trial of BNC105P in combination with BTK inhibitor ibrutinib in p...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center
Start Date
2018-03-09
Trial ID
NCT03454165
This is a two-part, non-randomized, open-label Phase I clinical study. The ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07169565
Treatments Being Tested
SNX-5422 is a prodrug of SNX-2112, a potent, highly selective, small molecu...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2017-02-07
Trial ID
NCT02973399
Treatments Being Tested
The purpose of this Phase 1/2 study is to evaluate the safety and efficacy ...
Status
Terminated
Location
University of California Irvine Health Chao Family Comprehensive Cancer Center
Start Date
2018-12-01
Trial ID
NCT03684694
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of ibrutinib w...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2017-01-12
Trial ID
NCT02950220
Treatments Being Tested
This phase II trial studies the effects of ibrutinib in treating patients w...
Status
Withdrawn
Location
Mayo Clinic in Rochester
Start Date
2020-11-23
Trial ID
NCT04665115
Treatments Being Tested